Enzo Biochem

These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.
Type
Public
HQ
New York, US
Founded
1976
Employees
443 (est)
Enzo Biochem was founded in 1976 and is headquartered in New York, US

Enzo Biochem Locations

New York, US

Enzo Biochem Metrics

Enzo Biochem Summary

Market capitalization

$335 M

Closing share price

$6.67
Enzo Biochem's latest market capitalization is $335 M.

Enzo Biochem Market Value History

Enzo Biochem News

Enzo Biochem Company Life

You may also be interested in